Adissp activates insulin-independent glucose disposal and energy expenditure in white fat to treat diabetes and cardiometabolic disease
Science Advances · 24.04.2026 · 12 (17)
DOI: 10.1126/sciadv.aed2780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 24.04.2026. Verfasst von Lei Huang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA. Hauptthemen laut MEDLINE: Energy Metabolism, Glucose, Adipose Tissue, White, Adipokines. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, National Institutes of Health, American Diabetes Association.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Whether a pharmacological strategy can replicate the broad improvement of human cardiometabolic health associated with brown fat (BAT) remains an active area of investigation. Here, we show that adipokine Adissp activates both glucose disposal and energy expenditure within white fat, delivering pleiotropic metabolic benefits. Endogenous Adissp is essential for glucose homeostasis. Administration of recombinant Adissp (rAdissp) protein sustainably normalizes hyperglycemia in type 1 and type 2 diabetic mice by activating insulin-independent Akt signaling. Furthermore, rAdissp robustly induces a comprehensive thermogenic program, which not only reduces body weight but also independently ameliorates a wide range of cardiometabolic diseases. Thus, a single adipokine, Adissp, recapitulates the systemic metabolic benefits of BAT and essentially functions as a cold mimetic. These findings reveal an unanticipated insulin-independent glucose uptake pathway and offer mechanistic insights into the cardiometabolic protection linked to human BAT. Adissp and its analogs represent a promising class of therapeutic agents to concurrently and synergistically treat diabetes and cardiometabolic diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular, Cell and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
- Li Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School, Worcester, MA, USA.
- Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Chan Medical School, Worcester, MA, USA.
- Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, MA, USA.
- German Center for Child and Adolescent Health (DZKJ), partner site Ulm, Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, University Medical, Center Ulm, Ulm 89075, Germ…
ORCID-Profile: Lei Huang, Pengpeng Liu, Qingbo Chen, Kai Hu, Shaoxian Li, Alexandra Lee, Martin Wabitsch, Lihua Julie Zhu, Qing Yu, Roger Davis, Scot A Wolfe, Yong-Xu Wang
Förderung
- NIDDK NIH HHS
- National Institutes of Health
- American Diabetes Association
- Bundesministerium für Forschung, Technologie und Raumfahrt
Zitieren
APA
Huang, L., Liu, P., Chen, Q., Hu, K., Li, S., Lee, A., Wabitsch, M., Zhu, L. J., Yu, Q., Davis, R., Czech, M. P., Wolfe, S. A., & Wang, Y. X. (2026). Adissp activates insulin-independent glucose disposal and energy expenditure in white fat to treat diabetes and cardiometabolic disease. Science Advances, 12(17). https://doi.org/10.1126/sciadv.aed2780
Vancouver
Huang L, Liu P, Chen Q, Hu K, Li S, Lee A, et al. Adissp activates insulin-independent glucose disposal and energy expenditure in white fat to treat diabetes and cardiometabolic disease. Science Advances. 2026;12(17). doi:10.1126/sciadv.aed2780
BibTeX
@article{Huang2026,
author = {Huang, Lei and Liu, Pengpeng and Chen, Qingbo and Hu, Kai and Li, Shaoxian and Lee, Alexandra and Wabitsch, Martin and Zhu, Lihua Julie and Yu, Qing and Davis, Roger and Czech, Michael P and Wolfe, Scot A and Wang, Yong-Xu},
title = {Adissp activates insulin-independent glucose disposal and energy expenditure in white fat to treat diabetes and cardiometabolic disease},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {17},
doi = {10.1126/sciadv.aed2780}
}
EUVIMED